Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

June 05, 2026
Vol.52 No.22
By Claire Marie Porter
As rural cancer disparities persist, aligning policy with care delivery models can close the gap
Trials & Tribulations

As rural cancer disparities persist, aligning policy with care delivery models can close the gap

May 29, 2026
Vol.52 No.21
By Matthew L. Anderson
“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
Cancer History ProjectFreePodcast

“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process

May 15, 2026
Vol.52 No.19
By Claire Marie Porter
In Brief

LSU LCMC Health cancer center strengthens cancer clinical trials infrastructure to expand access across Louisiana

May 15, 2026
Vol.52 No.19
Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Cancer History ProjectEditorial

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget
Fox Chase’s Winn contemplates Crossroads 2.0

April 17, 2026
Vol.52 No.15
By Paul Goldberg
Bridging communication and genomics: A path toward equitable cancer care
Sponsored

Bridging communication and genomics: A path toward equitable cancer care

April 17, 2026
Vol.52 No.15
By Stacy W. Gray
Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities
In Brief

Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities

April 17, 2026
Vol.52 No.15
HHS presents new protein-forward dietary guidelines, turning the food pyramid upside down
News Analysis

HHS presents new protein-forward dietary guidelines, turning the food pyramid upside down
The Kennedy guidelines are mum on cancer risks associated with red meat and alcohol

April 03, 2026
Vol.52 No.13
By Claire Marie Porter
In Brief

Roswell Park brings lung healthcare initiative to indigenous communities across North America

April 03, 2026
Vol.52 No.13
The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
PodcastThe Directors

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

February 27, 2026
Vol.52 No.08
By Claire Marie Porter and Paul Goldberg

Posts navigation

12…29Next

Trending Stories

  • Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Pam Bondi diagnosed with thyroid cancer
  • The story of daraxonrasib is the ultimate hero’s journey
    A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe
  • As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
  • At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account